Catherine Stehman-Breen
2017
In 2017, Catherine Stehman-Breen earned a total compensation of $1.8M as Former Senior Vice President, Chief Medical Officer at Sarepta Therapeutics.
Compensation breakdown
| Option Awards | $1,447,210 |
|---|---|
| Salary | $288,173 |
| Other | $65,446 |
| Total | $1,800,829 |
Stehman-Breen received $1.4M in option awards, accounting for 80% of the total pay in 2017.
Stehman-Breen also received $288.2K in salary and $65.4K in other compensation.
Rankings
In 2017, Catherine Stehman-Breen's compensation ranked 6,018th out of 14,666 executives tracked by ExecPay. In other words, Stehman-Breen earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,018 out of 14,666 | 59th |
Division Manufacturing | 2,210 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 696 out of 2,075 | 67th |
Industry group Drugs | 538 out of 1,731 | 69th |
Industry Pharmaceutical Preparations | 424 out of 1,333 | 68th |
Source: SEC filing on April 26, 2018.
Stehman-Breen's colleagues
We found six more compensation records of executives who worked with Catherine Stehman-Breen at Sarepta Therapeutics in 2017.
2017
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2017
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2017
Guriqbal Basi
Sarepta Therapeutics
Chief Scientific Officer
2017
Alexander Cumbo
Sarepta Therapeutics
Senior Vice President, Chief Commercial Officer
2017
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2017
David Howton
Sarepta Therapeutics